WeVote

Bill

Bill

HB 151

Relating to designating certain substances as Schedule IV controlled substances under the Texas Controlled Substances Act.

89th Legislature, 2nd Called Session (2025) Introduced by Shelley Luther and 1 co-sponsor

Bill reclassifies unspecified substances as Schedule IV controlled drugs in Texas, potentially increasing criminal penalties and affecting medical availability.

Referred to State Affairs
0
WeVote Research Nonpartisan
Bill Summary · HB 151

Legislative bill overview

HB 151 proposes to reclassify certain substances as Schedule IV controlled substances under Texas law. Schedule IV represents a middle tier of drug scheduling, indicating substances with accepted medical uses but moderate abuse potential. The bill would expand the list of substances subject to this classification level in the state's controlled substances framework.

Why is this important

Drug scheduling directly affects criminal penalties, medical availability, and enforcement priorities. Moving substances to Schedule IV can increase criminal penalties for possession and distribution while potentially affecting legitimate medical and pharmaceutical access. This reflects state-level drug policy decisions that impact public health, criminal justice, and healthcare practices across Texas.

Potential points of contention

  • Specificity unclear: The bill summary doesn't identify which specific substances are being rescheduled, making it difficult to assess whether the changes target synthetic drugs, prescription medications, or other categories
  • Medical vs. enforcement priorities: Stakeholders may disagree on whether reclassification appropriately balances legitimate medical access against abuse prevention
  • Consistency with federal law: Questions may arise about alignment with DEA scheduling and whether Texas is creating inconsistencies in drug classification across state and federal systems

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.